Typically, before a drug can be marketed, it must pass through a series of clinical trials, in order to identify safe dosages and to determine that any positive outcomes are due to the substance itself, and not to bias in the study design
BPC-157 (Body Protection Compound-157) to syntetyczny pentadekapeptyd skadajcy si z 15 aminokwasw, ktrego sekwencja zostaa wyprowadzona z fragmentu wikszego biaka naturalnie obecnego w ludzkim soku odkowym
Phase one of this four-phase trial has already concluded that TZP reduced systolic blood pressure (SBP) in 2,539 obese patients compared to placebos
Market Options of GHK-Cu GHK-Cu is an ingredient that's primarily used in skincare and in research
Department of Health and Human Services & USDA
Specialization in Delivery Formats: Growth in pre-filled, sterile vials for clinical or premium use